Manufacturers of antibiotics are dumping waste into waterways that is driving antimicrobial resistance (AMR), warns the first-ever guidance from the World Health Organization (WHO) on waste water management and AMR. Antibiotic pollution is “largely unregulated” and a “neglected” issue,  according to the WHO guidance, which explains how to mitigate liquid and solid waste during the formulation […] Continue reading ->
The fight against malaria is facing a new and urgent challenge as climate change and extreme weather events threaten to undermine decades of progress, according to warnings from several countries at the 77th World Health Assembly this week. “Recent extreme weather events such as flooding in Malawi and other countries have intensified malaria transmission, disproportionately […] Continue reading ->
At the 77th World Health Assembly, Gavi, The Vaccine Alliance, urged nations to prioritize vaccinating “zero-dose” children, particularly those in regions affected by humanitarian crises and complex emergencies. These children have not received any shots, putting them at a higher risk of preventable diseases. “We are scaling up routine immunization and reaching the estimated 14.3 […] Continue reading ->
Senior WHO officials sounded a cautiously optimistic note Tuesday about the prospects for WHO member states to somehow wrap up down-to-the-wire negotiations on a landmark Pandemic Accord in time to submit a final agreement to the World Health Assembly, which begins next Monday, 27 May. Meanwhile, they heralded the milestone agreement “in principle” to amend […] Continue reading ->
The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats.  The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading ->
The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir  “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading ->